课题基金 / 基金详情

Biodegradable Antibacterial Nanoparticles: The Next Generation of Antibiotics

Biodegradable Antibacterial Nanoparticles: The Next Generation of Antibiotics
可生物降解的抗菌纳米颗粒:下一代抗生素
批准号:
700594
负责人:
金额:
$3.16万
依托单位:
依托单位国家:
英国
项目类别:
GRD Proof of Market
财政年份:
2015
资助国家:
英国
项目状态:
已结题
起止时间:
2015 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Nosocomial infections caused by multidrug-resistant microorganisms such as MRSA and P.aeruginosa are observed frequently in hospital settings; resulting in serious public health problems. The most pressing concern is that they are becoming resistant to almost all antibiotics available at the present time. Nanomedicine offers new possibilities including fewer side effects, minimal damages to human cells, and lower drug concentrations and stability for a longer period. However, despite this significant potential, the translation ofnanoparticles to clinical practice is limited by their non-biodegradable nature and long-term toxicity. Hence antimicrobial biodegradable nanoparticles of polyesters and magnesium are an attractive proposition. Initial research from LIG Biowise has demonstrated the feasibility of a new technique that can generate these nanoparticles using picosecond laser ablation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金